FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| OurPharma LLC | 041422637 | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 10 ug/1 mL | 2022-1 | valid | 2026-11-12 | |
| OurPharma LLC | 041422637 | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 50 ug/1 mL | 2022-1 | valid | 2026-11-12 | |
| OurPharma LLC | 041422637 | 73013-1016 | 73013-1016-1 | Fentanyl Citrate | 10 ug/1 mL | 2022-1 | valid | 2026-11-12 | |
| OurPharma LLC | 041422637 | 73013-1014 | 73013-1014-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2 ug/1 mL; 1.25 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| OurPharma LLC | 041422637 | 73013-2000 | 73013-2000-1 | Ketamine Hydrochloride | 50 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| OurPharma LLC | 041422637 | 73013-2000 | 73013-2000-2 | Ketamine Hydrochloride | 50 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Chloride | 20 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride | 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride; Gentamicin Sulfate | 1 mg/.12 mL; 4 mg/.12 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 g | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Ceftazidime | 22.5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Cefuroxime Sodium | 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Epinephrine Hydrochloride; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | 6-6-Dideuteroglucose | 72.9 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Glycerin | 11.7 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride | 40 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride | 40 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride | 20 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 20 mg/1 mL; .25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 20 mg/1 mL; .25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1.5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| PQ Pharmacy LLC | 117479731 | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/5.6 mL; 5 mg/5.6 mL; .9 mg/5.6 mL | 2022-1 | valid | 2026-11-12 | |
| PQ Pharmacy LLC | 117479731 | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/5.6 mL; 5 mg/5.6 mL; .9 mg/5.6 mL | 2022-1 | valid | 2026-11-12 | |
| Prisma Health Outsourcing facility | 117222965 | 73463-300 | 73463-300-04 | Norepinephrine Bitartrate | .032 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Prisma Health Outsourcing facility | 117222965 | 73463-301 | 73463-301-04 | Phenylephrine Hydrochloride | .2 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Prisma Health Outsourcing facility | 117222965 | 73463-103 | 73463-103-06 | Ketamine Hydrochloride | 5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Prisma Health Outsourcing facility | 117222965 | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Prisma Health Outsourcing facility | 117222965 | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Oxytocin | .06 U/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | 70214-4010 | 70214-4010-1 | "fentanyl; Bupivacaine, (r)-" | 500 ug/250 mL; 250 mg/250 mL | 2022-1 | valid | 2026-11-12 |